
A Novel, Rapid Chip-Based iCIEF-MS Analysis of Therapeutic mAb Charge Variants Under Forced Degradation Conditions and Comparison to Traditional Methods

Speaker Presentation Donnelly Daniel, Merck & Co. Inc, 2020
A Novel, Rapid Chip-Based iCIEF-MS Analysis of Therapeutic mAb Charge Variants Under Forced Degradation Conditions and Comparison to Traditional Methods